The traditional drug discovery pipeline, often taking over a decade and costing billions per approved therapy, is buckling under its own weight. This inefficiency has created an urgent need for a new approach, and the industry has found its answer in artificial intelligence. AI is being deployed as a powerful force multiplier, capable of turning the vast and growing mountains of biological data...
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt